Thrombophilia in patients with chronic immune thrombocytopenia

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

(2012) M. N. Saleh et al.   BLOOD

Elevated factor VIII levels and risk of venous thrombosis

(2012) P. Vince Jenkins et al.   BRITISH JOURNAL OF HAEMATOLOGY

Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study

(2010) Marianne T. Severinsen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

(2010) A. Sarpatwari et al.   HAEMATOLOGICA

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

(2010) Gregory Cheng et al.   LANCET

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of anti-CD40 ligand in immune thrombocytopenic purpura

(2008) Vivek L. Patel et al.   BRITISH JOURNAL OF HAEMATOLOGY